Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder

Weiller, Emmanuelle; Bisserbe, J.C.; Boyer, Pascal; Lépine, Jean‐Pierre; Lecrubier, Y.

doi:10.1192/bjp.168.2.169

Cited by 190 publications

(161 citation statements)

References 10 publications

Supporting

Mentioning

146

Contrasting

Unclassified

Order By: Relevance

“…For example, a French primary care study of the prevalence, recognition and treatment of social phobia found that detection rates were increased in the presence of comorbid depression (66%, compared with 53% in those without depression) [I] (Weiller et al, 1996). However the presence of a seemingly more pressing comorbid condition can result in sub-optimal treatment for the anxiety disorder.…”

Section: Recommendations: Increased Awareness Of Anxiety Disordersmentioning

confidence: 99%

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

et al. 2014

View full text Add to dashboard Cite

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.

show abstract

Section: Recommendations: Increased Awareness Of Anxiety Disordersmentioning

confidence: 99%

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Prema istraživanjima, učestalost socijalnog anksioznog poremećaja kreće se između 13,3% u SAD [10] i 14,4% u Evropi [11].…”

Section: Diskusijaunclassified

Socijalno statusna obilježja kao determinante socijalne fobije kod adolescenata

Kalajdžić

2012

Biomedicinska istraž.

View full text Add to dashboard Cite

Kratak sadržajUvod. Pristupajući istraživanju socijalne fobije, namjera je bila da se doprinese razjašnjenju nekih aspekata ovog fenomena. Predmet istraživanja je socijalna fobija kod adolescenata, kao i provjera da li je ova pojava uslovljena socijalno -statusnim karakteristikama ispitanika.Metode. Od istraživačkih metoda korišten je metod teorijske analize primarnih i sekundarnih izvora i servej metod. Podaci su prikupljani upitnikom o socijalno -statusnim obilježjima i skalom procjene socijalne fobije. Uzorak ispitanika obuhvatio je 200 adolescenata. Za obradu podataka primjenjene su mjere srednjih vrijednosti i odstupanja od tih vrijednosti i mjere statističke značajnosti razlika među segmentima ukrštenih varijabli.Rezultati. Dobijeni podaci prvo su prikazani kao distribucija intenziteta socijalne fobije, a potom je sagledana priroda odnosa između zavisne varijable i nezavisnih varijabli. Rezultati pokazuju da 133 (66,5%) ispitanika posjeduje nizak stepen socijalne fobije, kod 44 (22,0%) ispitanika prisutna je umjerena socijalna fobija i kod 23 (11,5%) ispitanika simptomi socijalne fobije veoma su izraženi. U ispoljavanju socijalne fobije kod ispitanika muškog i ženskog pola postoje velike sličnosti i neznatne razlike. Razlike u ispoljavanju socijalne fobije kod prvorođene i drugorođene djece, takođe, nisu statistički značajne, a ne postoji ni statistički značajna povezanost između socijalne fobije i obrazovnog uzrasta.Zaključak. Najveći procenat ispitanika pokazuje nizak i umjeren nivo socijalne fobije (88,5%),a prevalenca izražene socijalne fobije kod adolescenata je 11,5%. Socijalno-statusna obilježja (pol, redoslijed rođenja i obrazovni uzrast) nisu značajne determinante koje utiču na intenzitet socijalne fobije.Ključne riječi: socijalna fobija, fobični strah, adolescencija UvodJedna od najčešćih smetnji u razvoju predadolescenata i adolescenata, posebno studenata, je socijalni strah. No, na sreću, socijalni strah je najčešće normalna pojava. Nema osobe koja nije osjetila napetost ili nelagodnost pri susretu sa važnim osobama, ili, pak, kada je trebalo javno da nastupa ili nešto da uradi pred

show abstract

“…More than 80% of people who suffer from social phobia have another comorbid disorder (14,15). This disorder causes more pervasive problems than other anxiety disorders (15)(16)(17)(18). Retrospective and prospective epidemiological studies suggest that social phobia can create confusion and deep problems in life, including problems in school and college achievement (2,11,18) and can disrupt job performance (15,16) and social development (2,15,16).…”

Section: Introductionmentioning

confidence: 99%

Short-term Dynamic Psychotherapy Versus Sertraline in the Treatment of Social Phobia

Moghadam

Atef-Vahid

Farid

et al. 2015

Iran J Psychiatry Behav Sci

View full text Add to dashboard Cite

Background: A few studies on short-term psychodynamic approach have been conducted on social phobia. Objectives: In this study, the effectiveness of short-term psychodynamic psychotherapy on the treatment of social phobia has been compared to the effectiveness of sertraline and waiting list. Materials and Methods: In this randomized-controlled trial study, 13 male students were treated with short-term dynamic psychotherapy (McCullough method) lasting 25 sessions, 11 students received sertraline for 12 weeks, and 14 students, as the waiting list, received no intervention for 8 weeks. Participants completed the Social Phobia Inventory (SPIN) as primary efficacy variable 4 times, and were rated with Clinical Global Impression scale (CGI) and Global Assessment of Functioning (GAF) as secondary efficacy variables. The data were analyzed with analysis of variance (ANOVA), analysis of covariance (ANCOVA), general linear model repeated measures analysis of variance and Fisher exact test. Results: ANCOVA showed significant differences between groups based on SPIN scores (F = 23.51, Sig. = 0.001) and Bonferroni test, as post hoc compression, showed means of both short-term dynamic therapy and sertraline therapy groups were significantly different from waiting list mean (STDP-WL:

show abstract

Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder

Abstract: SP appears to be a true and frequently severe pathological condition. The awareness of GPs and the general population should be improved.

Cited by 190 publications

References 10 publications

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Socijalno statusna obilježja kao determinante socijalne fobije kod adolescenata

Short-term Dynamic Psychotherapy Versus Sertraline in the Treatment of Social Phobia

Contact Info

Product

Resources

About